Member Info for Prion25

Still we wait

Must be significant data other than just safe ? It’s hopefully a Godsend for children and adolescents

Good bit of research on Brain FAP D-Geeman warrants a question at webinar

------

UBS cuts Ceres Power price target to 120 (480) pence - 'buy'

Never expected I would be buying a few more shares tonight almost gave up on these shares after they delisted Foralumab nasal treatment is unique and appears safe and the PET scans are compelling

Coincidently 8th May 2025 →9th May 2025

Data Centre Energy Efficiency & Sustainability Summit UK & Ireland

London, England, UK

See Events Ceres Website for mor details

Nick Lawrence, Chief Product Officer, and Huntly Thomas, System Applications Lead, will be attendi

** sorry JP Jenkins

FL

I have emailed investor relations ir@redxpharma.com not expecting anything . Its been a real muddle between communication between H&L and J P Morgan that has led me to this predicament I will let you know what transpires

P

Now they tell me H &L won’t be able trade these shares held with them!

Https://www.alainelkanninterviews.com/virgilio-sacchini-4/

Remember him? Oncologist would disagree with FUD

Smokingjoe

Thanks I needed reminding

Green hydrogen Projects such as Hyspeed in the UK will be a boost to electrolyser manufactures like ITM .Bosch ended their partnership with Ceres to concentrate solely on massively increasing the green hydrogen economy Where will this leave Ceres ? Ceres will be focused on clean energy by SOFC power delivery to industry ,maritime ,data centres and filling the gap in left by wind and solar as in Spain /Portugal yesterday ? imho

Rorydinho

Its the Bystander Effect

They "veered "towards SC I thought was a master stroke not because there was no lack of efficacy in STC but they had a strong signal AVA6000 and and pursued the treatment because of the great unmet need as there is no known treatment for SC The the data could be captured quickly and validate the platform .STC and TNBC data will follow

At the same time RBC cuts Ceres Power price target to 90 (110) pence - 'sector perform'

Who do you follow ?

Tempus AI collaboration will be interesting and looking forward to meticulous data on TME and FAP and further validation of the Precision platform

The AI view presumably gives analysis of the Abstract There are three posters being presented hopefully there will be novel compelling and cogent data to support this . Very exciting

BG sold Avacta completely 31 March 2025 underwhelming efficacy they must known the salivary gland cancer data ? I'm off to bed

Theracryf still hanging in at a glance

Tennents

I was just playing devil's advocate out of frustration . There seems so much potential in Ceres tech especially now steel making and clean energy is very topical in the UK media atm

GLA